A Win For NovaBay Pharmaceuticals, Inc.
Fri, Dec 19, 2025 at 07:33 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) shot up at $5.3, a gain of 79.7%. On Fri, Dec 19, 2025, NBY:NYSEMKT touched a New 2-Week High of $5.3. The stock appeared on our News Catalysts scanner on Fri, Dec 19, 2025 at 10:45 AM in the 'INVESTOR UPDATE' category. From Fri, Dec 05, 2025, the stock recorded 70.00% Up Days and 81.82% Green Days
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- Luminar Technologies, Inc. (LAZR:NASDAQ), 174.73%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 79.66%
- Mint Incorporation Limited (MIMI:NASDAQ), 75.45%
- Autozi Internet Technology (Global) Ltd. (AZI:NASDAQ), 64.47%
- GD Culture Group Limited (GDC:NASDAQ), 51.59%
- SOS Limited (SOS:NYSE), 47.65%
- Impact BioMedical Inc. (IBO:NYSEMKT), 46.26%
- Safe and Green Development Corporation (SGD:NASDAQ), 42.26%
- Cypherpunk Technologies Inc Com (New) (CYPH:NASDAQ), 39.02%
- Intuitive Machines, Inc. (LUNR:NASDAQ), 37.7%